674 related articles for article (PubMed ID: 23954492)
1. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
3. Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.
Helliwell RM; ShioukHuey CO; Dhuna K; Molero JC; Ye JM; Xue CC; Stokes L
Br J Pharmacol; 2015 Jul; 172(13):3326-40. PubMed ID: 25752193
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of the rhesus macaque monkey P2X7 receptor.
Bradley HJ; Browne LE; Yang W; Jiang LH
Br J Pharmacol; 2011 Sep; 164(2b):743-54. PubMed ID: 21457228
[TBL] [Abstract][Full Text] [Related]
5. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors.
Nörenberg W; Sobottka H; Hempel C; Plötz T; Fischer W; Schmalzing G; Schaefer M
Br J Pharmacol; 2012 Sep; 167(1):48-66. PubMed ID: 22506590
[TBL] [Abstract][Full Text] [Related]
6. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.
Nörenberg W; Hempel C; Urban N; Sobottka H; Illes P; Schaefer M
J Biol Chem; 2011 Apr; 286(13):11067-81. PubMed ID: 21262970
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine suppresses recombinant human P2X7 responses.
Dao-Ung P; Skarratt KK; Fuller SJ; Stokes L
Purinergic Signal; 2015 Dec; 11(4):481-90. PubMed ID: 26341077
[TBL] [Abstract][Full Text] [Related]
8. TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells.
Nörenberg W; Plötz T; Sobottka H; Chubanov V; Mittermeier L; Kalwa H; Aigner A; Schaefer M
J Gen Physiol; 2016 Jun; 147(6):467-83. PubMed ID: 27185858
[TBL] [Abstract][Full Text] [Related]
9. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
Donnelly-Roberts DL; Namovic MT; Surber B; Vaidyanathan SX; Perez-Medrano A; Wang Y; Carroll WA; Jarvis MF
Neuropharmacology; 2009 Jan; 56(1):223-9. PubMed ID: 18602931
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor antagonist activity of the anti-allergic agent oxatomide.
Yoshida K; Ito M; Matsuoka I
Eur J Pharmacol; 2015 Nov; 767():41-51. PubMed ID: 26463039
[TBL] [Abstract][Full Text] [Related]
11. ATP-induced currents carried through P2X7 receptor in rat myometrial cells.
Miyoshi H; Yamaoka K; Urabe S; Kudo Y
Reprod Sci; 2012 Dec; 19(12):1285-91. PubMed ID: 22814097
[TBL] [Abstract][Full Text] [Related]
12. Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons.
Sánchez-Nogueiro J; Marín-García P; Bustillo D; Olivos-Oré LA; Miras-Portugal MT; Artalejo AR
Eur J Pharmacol; 2014 Dec; 744():190-202. PubMed ID: 25446427
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264.7 and human embryonic kidney 293 cells.
Cankurtaran-Sayar S; Sayar K; Ugur M
Mol Pharmacol; 2009 Dec; 76(6):1323-32. PubMed ID: 19749088
[TBL] [Abstract][Full Text] [Related]
14. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor.
Virginio C; Church D; North RA; Surprenant A
Neuropharmacology; 1997 Sep; 36(9):1285-94. PubMed ID: 9364483
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia.
Zhang XF; Han P; Faltynek CR; Jarvis MF; Shieh CC
Brain Res; 2005 Aug; 1052(1):63-70. PubMed ID: 16005856
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells.
Michel AD; Chessell IP; Hibell AD; Simon J; Humphrey PP
Br J Pharmacol; 1998 Nov; 125(6):1194-201. PubMed ID: 9863647
[TBL] [Abstract][Full Text] [Related]
17. Mapping a novel positive allosteric modulator binding site in the central vestibule region of human P2X7.
Bidula SM; Cromer BA; Walpole S; Angulo J; Stokes L
Sci Rep; 2019 Mar; 9(1):3231. PubMed ID: 30824738
[TBL] [Abstract][Full Text] [Related]
18. Purinergic P2X7 receptors mediate cell death in mouse cerebellar astrocytes in culture.
Salas E; Carrasquero LM; Olivos-Oré LA; Bustillo D; Artalejo AR; Miras-Portugal MT; Delicado EG
J Pharmacol Exp Ther; 2013 Dec; 347(3):802-15. PubMed ID: 24101734
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
[TBL] [Abstract][Full Text] [Related]
20. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
